Phenylephrine - RDD PharmaAlternative Names: Phenylephrine coated suppositories - RDD Pharma
Latest Information Update: 22 Sep 2015
At a glance
- Originator RDD Pharma
- Class Antihypotensives; Decongestants; Ethanolamines; Mydriatics; Small molecules; Urologics
- Mechanism of Action Alpha 1 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Faecal incontinence
Most Recent Events
- 22 Sep 2015 No recent reports on development identified - Phase-I/II for Faecal Incontinence (In volunteers) in Israel (Rectal)